Bacterial infections of the blood (bacteraemia)
Bacteraemia means bacterial infection of the blood. This is common in people with HIV because bacterial infections in organs such as the lungs or gut can spread into the bloodstream. Moreover, injecting drug users may inadvertently inject bacteria into their blood through unsterile injecting equipment, and medical procedures can either directly lead to infection (for example, through insertion of central venous lines) or indirectly (for example, drugs that cause the neutrophil count to fall).
Septic arthritis in HIV-infected haemophiliacs has been linked to bacterial infections. Antibiotics are usually sufficient to resolve the arthritis.
The two most common causes of bacteraemia are Staphylococcus aureus and the so-called 'Gram negative' bacteria. Different bacteria are treated with different antibiotics. Catheter-associated infections may initially be treated with antibiotics leaving the catheter in place, but if the individual is acutely ill or has persistent fever or bacteraemia it is usually necessary to remove the catheter.
An antibiotic-resistant form of S. aureus, known as methicillin-resistant S. aureus (MRSA), has become relatively common worldwide. It can affect both HIV-negative and HIV-positive people, causing severe illness. It usually responds to treatment with antibiotics such as vancomycin (Vancocin) or teicoplanin (Targocid). Salmonella is also a common cause of bacteraemia worldwide.
As many as 50% of HIV-positive people with bacteraemia may have no symptoms. However, untreated bacterial infections can become very serious. Serious blood infection is known as septicaemia, and requires urgent treatment. Consequently, it is necessary to make a 'best guess' of the right antibiotics to give before laboratory results confirm this diagnosis.
latest aidsmap news
- High early mortality after starting antiretroviral treatment in Africa
- Nobel prize awarded to French discoverers of HIV
- Fall in number of undiagnosed HIV infections in the US
- Higher levels of drug resistance seen after first-line NNRTI failure than boosted PI failure: meta-analysis
- Wide variation found in anal HPV viral loads in HIV-positive men
- Offering rapid point-of-care tests would increase uptake of HIV testing
- Low rate of spontaneous hepatitis C clearance in patients with HIV; early HIV treatment recommended for those with chronic hepatitis C infection
- Cluster of multi-drug resistant HIV transmissions in Seattle
- Hypersensitivity testing for abacavir slightly more cost-effective than tenofovir use, if both drugs equally potent
- HIV no longer bar to granting of US visa for short visits
